IRCT2017091136125N1招募中3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by AC regimn in patients with non metastatic breast cancer
Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- Female
入选标准
- •Non-metastatic breast cancer that has undergone chemotherapy with cyclophosphamide + doxorubicin after mastectomy; Grade 2 or higher grade liver toxicity based on NCI-CTC version4 based on AST, ALT or Bilirubin level that will be evaluated at the beginning of each chemotherapy course; Age between 18 to 65 years
- •Exclusion criteria: Patients with viral hepatitis (A, B and C); hepatobiliary obstruction; history of hepatic or renal; malabsorbtion syndrome ; gastrointestinal obstruction ; patients dissatisfaction; co-administration of hepatotoxic medications; consumption of antioxidant medication; chemotherapy regimen modification
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Evaluation of silymarin tablet efficacy in prevention of hepatotoxicity induced by doxorubicin containing chemotherapy regimen in patients with non-metastatic breast cancerIRCT20200408046990N6Mashhad University of Medical Sciences50
已完成
2 期
the evaluation of effectiveness of oral silymarin on memory status of patients with dementiaCondition 1: Dementia in Alzheimer disease. Condition 2: Vascular dementia. Condition 3: Dementia in other diseases classified elsewhere.Alzheimer disease is a primary degenerative cerebral disease of unknown etiology with characteristic neuropathological and neurochemical features. The disorder is usually insidious in onset and develops slowly but steadily over a period of several years.Vascular dementia is the result of infarction of the brain due to vascular disease, including hypertensive cerebrovascular disease. The infarcts are usually small but cumulative in their effect. Onset is usually in later life.Cases of dementia due, or presumed to be due, to causes other than Alzheimer disease or cerebrovascular disease. Onset may be at any time in life, though rarely in old age.IRCT201505091856N5Vice-chancellor for research, Kermanshah University of Medical Sciences100
招募中
3 期
Evaluation of oral nano-silymarin formulation effect in prevention of liver damage induced by doxorubicin-cyclophosphamide chemotherapy regimen in patients with non-metastatic breast canceron-metastatic breast cancer.Malignant neoplasm of breastIRCT20200408046990N13Mashhad University of Medical Sciences70
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60